UPB Upstream Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$5,04
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$4,87rendah 52m
$33,68tinggi 52m
Kapitalisasi Pasar (MRQ)
$276M
P/E (TTM)
-1.7
EPS (TTM)
$-2.89
Pendapatan (TTM)
$3M
lencana Anda
Rentang 52M
$5–$34
Peringkat Analis
BUY
Target Harga
$31
P/E
-1.7
ROE
-46.0%
Margin Laba Bersih
-4955.7%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
UPB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$5.04
Kapitalisasi Pasar (MRQ)
$276M
P/E (TTM)
-1.7
EPS (TTM)
$-2.89
Pendapatan (TTM)
$3M
ROE (TTM)
-46.0%
Rentang 52M
$5–$34
UPB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$3M2023-12-31 → 2025-12-31
EPS$-2.662023-12-31 → 2025-12-31
Arus Kas Bebas$-133M2024-12-31 → 2025-12-31
Margin bersih-4955.7%2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | UPB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -1.7 | · | · | · | |
| P/S (TTM) | 87.4 | · | 49.8 | Terlalu mahal | |
| P/B (MRQ) | 1.0 | · | 1.7 | Kurang nilai | |
| Price / FCF (Harga / FCF) | -2.0 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -2.1 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.8 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | UPB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -5382.6% | · | -871.1% | Lemah | |
| Margin EBITDA (TTM) | -5376.3% | · | -871.1% | Lemah | |
| Margin Laba Bersih (TTM) | -4955.7% | · | -871.2% | Lemah | |
| ROA (TTM) | -44.6% | · | -35.9% | Tingkat teratas | |
| ROE (TTM) | -46.0% | · | -51.9% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | UPB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 28.0 | · | 7.7 | Likuiditas kuat | |
| Rasio Cepat (MRQ) | 26.2 | · | 6.3 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | UPB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 20.4% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | UPB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0 | · | 0.0 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 4.5 | · | 3.6 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$38.1K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-26.7%
Laporan Berikutnya
Nov 03, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 12, 2026 | $-0.73 | $-0.77 | 5.0% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.75 | $-0.78 | 4.0% |
| 31 Des. 2025 | $-0.79 | $-0.71 | -11.2% | |
| 30 Sep. 2025 | $-0.63 | $-0.79 | 20.2% | |
| 30 Juni 2025 | $-0.74 | $-0.62 | -19.6% | |
| 31 Maret 2025 | $-0.51 | $-0.49 | -4.1% | |
| 31 Des. 2024 | $-1.59 | $-0.57 | -181.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $3M | $2M | $2M | |
| R&D Expense | $137M | $63M | $32M | |
| SG&A Expense | $26M | $17M | $11M | |
| Operating Expenses | $163M | $80M | $42M | |
| Operating Income | $-160M | $-78M | $-40M | |
| Interest Income | $17M | $12M | $4M | |
| Other Non-op | $17M | $15M | $20M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-143M | $-63M | $-21M | |
| EPS (Basic) | $-2.66 | $-5.58 | $-12.95 | |
| EPS (Diluted) | $-2.66 | $-5.58 | $-12.95 | |
| Shares (Basic) | 53,852,752 | 13,682,326 | 2,953,756 | |
| Shares (Diluted) | 53,852,752 | 13,682,326 | 2,953,756 | |
| EBITDA | $-160M | $-78M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $102M | $326M | $26M | |
| Short-term Investments | $240M | $145M | $84M | |
| Receivables | $668.0K | $613.0K | $98.0K | |
| Prepaid Expense | $10M | $8M | $7M | |
| Other Current Assets | $727.0K | · | · | |
| Current Assets | $352M | $479M | $117M | |
| PP&E (Net) | $559.0K | $582.0K | $159.0K | |
| PP&E (Gross) | $903.0K | $738.0K | $226.0K | |
| Accum. Depreciation | $344.0K | $156.0K | $67.0K | |
| Goodwill | · | $0 | · | |
| Total Assets | $354M | $482M | $117M | |
| Accounts Payable | $3M | $4M | $2M | |
| Current Liabilities | $13M | $11M | $7M | |
| Capital Leases | $549.0K | $1M | · | |
| Total Liabilities | $14M | $12M | $9M | |
| Common Stock | $54.0K | $53.0K | $3.0K | |
| Paid-in Capital | $673M | $661M | $5M | |
| Retained Earnings | $-334M | $-191M | $-128M | |
| AOCI | $530.0K | $-25.0K | $21.0K | |
| Stockholders' Equity | $340M | $470M | $-123M | |
| Liabilities + Equity | $354M | $482M | $117M | |
| Shares Outstanding | 54,237,750 | 53,603,398 | 2,992,479 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $188.0K | $89.0K | $60.0K | |
| Stock-based Comp | $10M | $6M | $3M | |
| Other Non-cash | $-352.0K | $-2M | · | |
| Operating Cash Flow | $-133M | $-59M | $-38M | |
| CapEx | $165.0K | $511.0K | $144.0K | |
| Investing Cash Flow | $-93M | $-59M | $-83M | |
| Financing Cash Flow | $2M | $419M | $130M | |
| Net Change in Cash | $-224M | $300M | $9M | |
| Free Cash Flow | $-133M | $-60M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -5618.8% | -3281.2% | · | |
| Net Margin | -5026.0% | -2650.0% | · | |
| EBITDA Margin | -5612.2% | -3277.4% | · | |
| ROA | -34.3% | -21.0% | · | |
| ROE | -38.3% | -40.6% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 26.2 | 44.6 | · | |
| Quick Ratio | 25.4 | 43.9 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 4.5 | 6.7 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $6.26 | $8.77 | · | |
| Revenue / Share | $0.05 | $0.17 | · | |
| Cash Flow / Share | $-2.47 | $-4.32 | · | |
| Cash / Share | $1.87 | $6.08 | · | |
| EPS (TTM) | $-2.66 | $-5.58 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 20.4% | -0.42% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $3M | $2M | · | |
| Net Income TTM | $-143M | $-63M | · | |
| Market Cap | $1.47B | $881M | · | |
| P/E | -10.2 | -2.9 | · | |
| P/S | 516.0 | 371.8 | · | |
| P/B | 4.3 | 1.9 | · | |
| P / Tangible Book | 4.3 | 1.9 | · | |
| P / Cash Flow | -11.0 | -14.9 | · | |
| P / FCF | -11.0 | -14.8 | · | |
| Earnings Yield | -9.8% | -33.9% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $773.0K | $1M | $668.0K | $683.0K | $937.0K | $566.0K | $613.0K | $607.0K | $510.0K | $640.0K | $450.0K | $621.0K | |
| R&D Expense | $36M | $37M | $40M | $33M | $38M | $26M | $22M | $15M | $14M | $12M | $12M | $8M | |
| SG&A Expense | $7M | $8M | $7M | $6M | $7M | $7M | $5M | $4M | $4M | $4M | $3M | $2M | |
| Operating Expenses | $43M | $45M | $47M | $39M | $45M | $33M | $27M | $20M | $18M | $16M | $15M | $10M | |
| Operating Income | $-42M | $-44M | $-46M | $-38M | $-44M | $-32M | $-26M | $-19M | $-18M | $-15M | $-14M | $-9M | |
| Interest Income | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $3M | $3M | $1M | $2M | $2M | |
| Other Non-op | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $3M | $3M | $4M | $2M | $6M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-40M | $-41M | $-42M | $-34M | $-40M | $-27M | $-21M | $-16M | $-15M | $-11M | $-12M | $-3M | |
| EPS (Basic) | $-0.73 | $-0.75 | $-0.78 | $-0.63 | $-0.74 | $-0.51 | $12.56 | $-6.96 | $-6.50 | $-4.68 | $-5.05 | $-2.11 | |
| EPS (Diluted) | $-0.73 | $-0.75 | $-0.78 | $-0.63 | $-0.74 | $-0.51 | $12.56 | $-6.96 | $-6.50 | $-4.68 | $-5.05 | $-2.11 | |
| Shares (Basic) | 54,567,976 | 54,332,319 | · | 53,930,946 | 53,770,868 | 53,617,723 | · | 3,023,155 | 3,008,807 | 2,995,607 | · | 2,958,727 | |
| Shares (Diluted) | 54,567,976 | 54,332,319 | · | 53,930,946 | 53,770,868 | 53,617,723 | · | 3,023,155 | 3,008,807 | 2,995,607 | · | 2,958,727 | |
| EBITDA | $-42M | $-44M | · | $-38M | $-44M | $-32M | · | $-19M | · | · | · | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $97M | $102M | $72M | $45M | $71M | $326M | $33M | · | · | $26M | · | |
| Short-term Investments | $182M | $198M | $240M | $300M | $348M | $360M | $145M | $188M | · | · | $84M | · | |
| Receivables | $772.0K | $1M | $668.0K | $683.0K | $937.0K | $566.0K | $613.0K | $607.0K | · | · | $98.0K | · | |
| Prepaid Expense | $18M | $21M | $10M | $16M | $24M | $22M | $8M | $6M | · | · | $7M | · | |
| Other Current Assets | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $280M | $316M | $352M | $389M | $418M | $454M | $479M | $227M | · | · | $117M | · | |
| PP&E (Net) | $460.0K | $510.0K | $559.0K | $616.0K | $544.0K | $539.0K | $582.0K | $578.0K | · | · | $159.0K | · | |
| PP&E (Gross) | $903.0K | $903.0K | $903.0K | $903.0K | $785.0K | $738.0K | $738.0K | $685.0K | · | · | $226.0K | · | |
| Accum. Depreciation | $443.0K | $393.0K | $344.0K | $287.0K | $241.0K | $199.0K | $156.0K | $107.0K | · | · | $67.0K | · | |
| Total Assets | $281M | $318M | $354M | $391M | $421M | $456M | $482M | $233M | · | · | $117M | · | |
| Accounts Payable | $2M | $2M | $3M | $4M | $3M | $5M | $4M | $5M | · | · | $2M | · | |
| Current Liabilities | $10M | $14M | $13M | $12M | $11M | $10M | $11M | $11M | · | · | $7M | · | |
| Capital Leases | $226.0K | $390.0K | $549.0K | $703.0K | $849.0K | $992.0K | $1M | $1M | · | · | · | · | |
| Total Liabilities | $10M | $14M | $14M | $13M | $12M | $11M | $12M | $12M | · | · | $9M | · | |
| Common Stock | $54.0K | $54.0K | $54.0K | $56.0K | $54.0K | $53.0K | $53.0K | $3.0K | · | · | $3.0K | · | |
| Paid-in Capital | $686M | $679M | $673M | $670M | $666M | $663M | $661M | $9M | · | · | $5M | · | |
| Retained Earnings | $-415M | $-375M | $-334M | $-292M | $-258M | $-218M | $-191M | $-170M | · | · | $-128M | · | |
| AOCI | $-123.0K | $100.0K | $530.0K | $493.0K | $258.0K | $368.0K | $-25.0K | $351.0K | · | · | $21.0K | · | |
| Stockholders' Equity | $271M | $304M | $340M | $379M | $409M | $446M | $470M | $-160M | · | · | $-123M | · | |
| Liabilities + Equity | $281M | $318M | $354M | $391M | $421M | $456M | $482M | $233M | · | · | $117M | · | |
| Shares Outstanding | 54,771,041 | 54,419,986 | 54,237,750 | 53,999,522 | 53,798,151 | 53,640,895 | 53,603,398 | 3,025,452 | · | · | 2,992,479 | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $50.0K | $49.0K | $57.0K | $46.0K | $42.0K | $43.0K | $49.0K | $14.0K | $13.0K | $13.0K | $14.0K | · | |
| Stock-based Comp | $4M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $643.0K | $711.0K | · | |
| Other Non-cash | · | $-12M | · | · | · | $-17M | · | · | · | · | · | · | |
| Operating Cash Flow | $-36M | $-48M | $-31M | $-22M | $-39M | $-41M | $-20M | $-14M | $-8M | $-18M | $-16M | · | |
| CapEx | · | · | $54.0K | $64.0K | · | · | $185.0K | · | · | · | $0 | · | |
| Investing Cash Flow | $16M | $42M | $59M | $48M | $13M | $-213M | $42M | $1M | $-117M | $14M | $-5M | · | |
| Financing Cash Flow | $3M | $598.0K | $1M | $760.0K | $612.0K | $-34.0K | $271M | $-2M | $141M | $9M | $-133.0K | · | |
| Net Change in Cash | $-17M | $-5M | $29M | $27M | $-26M | $-255M | $293M | $-14M | $16M | $6M | $-21M | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5481.0% | -4218.1% | · | -5539.4% | -4732.9% | -5656.0% | · | -3112.5% | · | · | · | · | |
| Net Margin | -5136.1% | -3925.6% | · | -4941.1% | -4265.3% | -4818.0% | · | -2634.6% | · | · | · | · | |
| EBITDA Margin | -5481.0% | -4213.3% | · | -5539.4% | -4732.9% | -5648.4% | · | -3112.5% | · | · | · | · | |
| ROA | -11.3% | -10.5% | · | -10.8% | -19.0% | -12.0% | · | -13.7% | · | · | · | · | |
| ROE | -11.7% | -10.8% | · | -30.9% | -19.6% | -12.2% | · | 20.0% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.0 | 23.1 | · | 32.7 | 38.3 | 47.4 | · | 20.9 | · | · | · | · | |
| Quick Ratio | 26.2 | 21.6 | · | 31.3 | 36.1 | 45.1 | · | 20.3 | · | · | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · | |
| Receivables Turnover | 0.9 | 1.3 | · | 1.1 | 2.0 | 2.0 | · | 2.0 | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.95 | $5.59 | · | $7.01 | $7.60 | $8.31 | · | $-52.99 | · | · | · | · | |
| Revenue / Share | $0.01 | $0.02 | · | $0.01 | $0.02 | $0.01 | · | $0.20 | · | · | · | · | |
| Cash Flow / Share | · | $-0.88 | · | · | · | $-0.77 | · | · | · | · | · | · | |
| Cash / Share | $1.45 | $1.78 | · | $1.34 | $0.84 | $1.33 | · | $10.89 | · | · | · | · | |
| EPS (TTM) | $-2.89 | $-2.90 | · | $10.68 | $4.35 | $-1.41 | · | $-23.19 | $-18.34 | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $2M | · | $2M | $2M | · | · | · | |
| Net Income TTM | $-156M | $-157M | · | $-122M | $-104M | $-79M | · | $-53M | $-41M | $-28M | · | · | |
| Market Cap | $379M | $490M | · | $1.02B | $591M | $328M | · | · | · | · | · | · | |
| P/E | -2.4 | -3.1 | · | 1.8 | 2.5 | -4.3 | · | · | · | · | · | · | |
| P/S | 120.0 | 147.4 | · | 362.9 | 216.9 | 143.0 | · | · | · | · | · | · | |
| P/B | 1.4 | 1.6 | · | 2.7 | 1.4 | 0.7 | · | · | · | · | · | · | |
| P / Tangible Book | 1.4 | 1.6 | · | 2.7 | 1.4 | 0.7 | · | · | · | · | · | · | |
| P / Cash Flow | · | -10.2 | · | · | · | -8.0 | · | · | · | · | · | · | |
| Earnings Yield | -41.8% | -32.2% | · | 56.8% | 39.6% | -23.0% | · | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Pendapatan | $3M | $2M | $2M |
| Margin Operasi % | -5618.8% | -3281.2% | · |
| Laba Bersih | $-143M | $-63M | $-21M |
| EPS Dilusian | $-2.66 | $-5.58 | $-12.95 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rasio Lancar | 26.2 | 44.6 | · |
| Rasio Cepat | 25.4 | 43.9 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Arus Kas Bebas | $-133M | $-60M | · |
Pemilik institusional (13F) 154 pengaju · $412.0M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
154
Nilai yang dipegang
$412.0M
Posisi baru
37
Posisi yang keluar
26
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 37 (-14 vs Kuartal sebelumnya) | 26 (-10 vs Kuartal sebelumnya) | 66 (+19 vs Kuartal sebelumnya) | 30 (-6 vs Kuartal sebelumnya) | +5.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $64.846.119 | 2.388.439 | 15,74% | Saham |
| FMR LLC | $56.487.247 | 8.162.897 | 13,71% | Saham |
| ORBIMED ADVISORS LLC | $39.399.636 | 5.693.589 | 9,56% | Saham |
| NORGES BANK | $26.078.843 | 3.768.619 | 6,33% | Saham |
| BlackRock, Inc. | $25.973.237 | 3.753.358 | 6,30% | Saham |
| Decheng Capital LLC | $18.856.087 | 2.724.868 | 4,58% | Saham |
| ENAVATE SCIENCES GP, LLC | $17.021.145 | 2.459.703 | 4,13% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.986.999 | 1.876.734 | 3,15% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.914.923 | 1.143.775 | 1,92% | Saham |
| D. E. Shaw & Co., Inc. | $7.169.425 | 1.036.044 | 1,74% | Saham |
| JPMORGAN CHASE & CO | $7.013.464 | 1.012.044 | 1,70% | Saham |
| Qube Research & Technologies Ltd | $6.771.220 | 978.500 | 1,64% | Saham |
| Parkman Healthcare Partners LLC | $6.471.909 | 935.247 | 1,57% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $6.445.888 | 931.261 | 1,56% | Saham |
| SEB Asset Management AB | $6.079.022 | 878.473 | 1,48% | Saham |
| Woodline Partners LP | $5.753.849 | 831.481 | 1,40% | Saham |
| STATE STREET CORP | $5.302.955 | 766.323 | 1,29% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.931.656 | 712.667 | 1,20% | Saham |
| Y-Intercept (Hong Kong) Ltd | $4.799.401 | 693.555 | 1,16% | Saham |
| Bain Capital Life Sciences Investors, LLC | $4.158.567 | 600.949 | 1,01% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $3.770.493 | 544.869 | 0,92% | Saham |
| MORGAN STANLEY | $3.630.453 | 524.632 | 0,88% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $3.539.898 | 511.546 | 0,86% | Saham |
| Walleye Capital LLC | $3.449.551 | 498.490 | 0,84% | Saham |
| Trexquant Investment LP | $3.227.696 | 466.430 | 0,78% | Saham |
| Point72 Asset Management, L.P. | $3.134.836 | 453.011 | 0,76% | Saham |
| BANK OF AMERICA CORP /DE/ | $2.710.993 | 391.762 | 0,66% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $2.640.811 | 381.613 | 0,64% | Saham |
| Altshuler Shaham Ltd | $2.630.022 | 380.061 | 0,64% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2.475.672 | 357.756 | 0,60% | Saham |
| SAMSARA BIOCAPITAL, LLC | $2.447.722 | 353.717 | 0,59% | Saham |
| Propel Bio Management, LLC | $2.424.692 | 350.389 | 0,59% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $2.369.083 | 342.353 | 0,57% | Saham |
| NORTHERN TRUST CORP | $2.057.634 | 297.346 | 0,50% | Saham |
| Squarepoint Ops LLC | $2.013.056 | 290.904 | 0,49% | Saham |
| Voleon Capital Management LP | $1.973.819 | 285.234 | 0,48% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.816.196 | 262.456 | 0,44% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.751.397 | 253.092 | 0,43% | Saham |
| GOLDMAN SACHS GROUP INC | $1.708.666 | 246.917 | 0,41% | Saham |
| XTX Topco Ltd | $1.677.034 | 242.346 | 0,41% | Saham |
| DEUTSCHE BANK AG\ | $1.670.814 | 241.447 | 0,41% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.658.143 | 239.616 | 0,40% | Saham |
| UBS Group AG | $1.624.221 | 234.714 | 0,39% | Saham |
| Schonfeld Strategic Advisors LLC | $1.562.258 | 225.760 | 0,38% | Saham |
| Jump Financial, LLC | $1.544.703 | 223.223 | 0,37% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $1.520.324 | 219.700 | 0,37% | Saham |
| Boxer Capital Management, LLC | $1.038.000 | 150.000 | 0,25% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $908.596 | 131.300 | 0,22% | Saham |
| EntryPoint Capital, LLC | $895.766 | 129.446 | 0,22% | Saham |
| ALGERT GLOBAL LLC | $820.920 | 118.630 | 0,20% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| AI Upstream LLC, Access Industries Holdings LLC, AI Biotechnology LLC, Access Industries Management, LLC, Len Blavatnik | 22 Okt. 2024 | · | Pengajuan awal | Investasi pasif | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Advisors Israel II Limited, OrbiMed Israel GP II, L.P. | 17 Okt. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 12 orang dalam · 5 pejabat · 7 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Everett Rand Sutherland | Chief Executive Officer | 16 Sep. 2026 S | 68.717 | 0 | 3 | $-43.726 |
| Michael Gray | CFO and COO | 16 Sep. 2026 S | 27.942 | 0 | 3 | $-17.801 |
| Allison Ambrose | General Counsel | 16 Sep. 2026 S | 15.563 | 0 | 3 | $-9.986 |
| Aaron Deykin | Chief Medical Officer | 16 Sep. 2026 S | 32.302 | 0 | 3 | $-18.679 |
| Adam Houghton | Chief Business Officer | 16 Sep. 2026 S | 22.901 | 0 | 3 | $-14.607 |
| Marcella K. Ruddy | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Harold Edward Fleming | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| CHIMOVITS EREZ | Direktur | 9 Juni 2026 A | 4.554.873 | 0 | 0 | $0 |
| Liam Ratcliffe | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Daniella Beckman | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Pemilik 10% | 15 Okt. 2024 C | 894.733 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 21 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,69% | 50.952 NS | 31 Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,04% | 93.712 NS | 31 Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.318 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 3.884 SH | 1 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,02% | 273.014 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 52.923 SH | 1 Okt. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 202.528 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 16.828 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 904.196 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 150.504 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 11.496 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.145 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2.366 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 49.983 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 9.669 SH | 3 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 6.279 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 386.877 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.443.025 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.529 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,00% | 72.742 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 336.197 SH | 11 Sep. 2026 | Harian |
UPB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$25.00
+396,0%
2 15,4%
Beli Kuat
8 61,5%
Beli
3 23,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
7 analis · 2026-10-01Target rata-rata $31.14 +517,9%
← Di bawah semua target
Harga saat ini $5.04
Rendah$9.00
Rata-rata$31.14
Tinggi$75.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| RCKT | · | · | · | · | · | · |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | · |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| ZSQR | · | · | · | · | · | · |
| SABS | · | · | · | · | · | · |
| TLSI | · | · | · | · | · | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026